RestorGenex Corp. (OTCQX: RESX) is a specialty biopharmaceutical company focused on the development of a portfolio of first-in-class therapeutic products to treat diseases across the oncologic, ophthalmologic and dermatologic space. The company’s lead product candidate, RES-529, is a novel PI3K/Akt/mTOR pathway inhibitor that has completed two phase I clinical trials for the treatment of age-related macular degeneration (AMD) and is in preclinical oncology development for the treatment of glioblastoma multiforme (GBM). RestorGenex has announced plans to initiate human clinical trials in GBM in 2016. Additionally, the company’s pipeline includes RES-440, a ‘soft’ anti-androgen compound for the treatment of acne vulgaris.

Through its ongoing development programs, RestorGenex is addressing a collection of underserved markets in the biopharmaceutical industry. According to industry data, the worldwide market for the treatment of GBM in 2013 was estimated at $1 billion, and that figure is expected to climb to $4.5 billion by 2020. Due to the modest effectiveness of currently available treatment options, this market performance could provide an opportunity for RestorGenex to achieve considerable financial growth upon commercialization of RES-529. The company’s innovative PI3K pathway inhibitor has also shown promise in a number of additional indications, which RestorGenex is currently evaluating for the purpose of creating safe and effective treatments.

“The scientific research and knowledge of RES-529 continues to expand, in particular for clinical oncology applications,” Stephen M. Simes, chief executive officer of RestorGenex, stated in a news release. “These new data help to validate our plans for future studies with RES-529, as well as suggest that its analogs could also be developed for oncology indications.”

Moving forward, RestorGenex will lean on the strength of its balance sheet as it progresses toward the commercialization of its promising development pipeline. As of June 30, 2015, the company reported cash and cash equivalents of approximately $16.5 million, which it expects to sufficiently fund its operations well into the second half of 2016. RestorGenex had no outstanding debt as of its latest financial filings.

For prospective shareholders, the potential marketability of RestorGenex’s development pipeline, particularly in oncology indications, could foreshadow an opportunity for the company to achieve considerable market growth in the future. Look for the company to continue benefitting from its favorable financial position as it advances its product candidates in the months to come.

For more information, visit www.restorgenex.com

Cherubim Interests is led by highly experienced directors and a notable management team proficient in specific disciplines of property management, construction and finance. The company has committed these specialties to sharpen the company’s focus on alternative construction and real estate development.

Primarily concentrated on the real estate development and controlled environment agriculture sectors, Cherubim Interests acquired an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Along these lines, the company plans on leveraging its wholly owned subsidiary, BudCube Cultivation Systems USA (“BCS”), to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Integrating real estate development and property management expertise, BCS has the ability to position itself anywhere in the world where the cultivation of cannabis is legal. This unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

The legal marijuana market is the fastest-growing industry in the United States, and while it’s a fairly new industry, people are investing millions of dollars in key niches of the market, such as cannabis cultivation for medicinal purposes.

BCS’s current short-term opportunity is based solely on the legalization of Oregon Medical and Recreational Cannabis:

• Medical cannabis sales represents a market of $60 mm / year.
• Recreational cannabis sales represents a market of $550 – 600 mm / year.
• Demand for technology is strong.
• Demand is outpacing capacity in the short run.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim Interests is strategizing to use its licensed solution to fulfill the needs of first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product.

For more information visit http://CHIT.QualityStocks.net

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

Avant Diagnostics, Inc. (OTC: AVDX) is a medical diagnostic technology company specializing in large panel biomarker screening. The company’s first test, OvaDx®, is being developed in conjunction with Arrayit Corporation (OTCQB: ARYC) as the market’s first large panel biomarker screening test for pre-symptomatic ovarian cancer. In preclinical research studies, OvaDx demonstrated high sensitivity and specificity for all types and stages of ovarian cancer – including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous and ovarian adenocarcinoma. Upon reception of FDA 510(k) clearance for OvaDx, Avant intends to sell or license the innovative technology as a diagnostic test for women seeking greater wellness.

When commercialized, the market for Avant’s sophisticated microarray-based test is likely to be immense. According to statistics from the American Cancer Society, ovarian cancer ranks fifth in terms of cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. In 2015, it’s estimated that more than 21,200 women will receive a new diagnosis of ovarian cancer in the United States. For these women, early diagnosis can be pivotal to surviving the disease. If diagnosed in stage I, the five-year survivability rate of ovarian cancer is 90 percent, but that statistic falls to 70 percent if diagnosis occurs in stage II, further demonstrating the considerable market need for highly sensitive testing technology such as OvaDx.

Avant is led by a management team with decades of related industry experience. The company’s president and chief executive officer, Gregg Linn, has been with Avant since December 2012. Prior to serving in this position, Linn held similar positions at two firms specializing in providing strategic financial and business development advisory services to public and non-public businesses.

Moving forward, Avant will look to lean on its experienced management team in order to continue making progress toward the commercialization of its groundbreaking OvaDx diagnostic tool. In April, the company announced the engagement of DOCRO, Inc. to manage the preparation and submission of required data as necessary to obtain a 510(k) clearance for OvaDx as an aid in monitoring women diagnosed with ovarian cancer. For prospective shareholders, this progress could foreshadow an opportunity for considerable financial growth in the future.

For more information, visit www.avantdiagnostics.com

In an effort to elevate its cosmeceutical and nutraceutical product lines, Hemp, Inc. recently announced a full media partnership and public relations agreement with Freedom Leaf, Inc. (OTC: FRLF), a leading marijuana-related news, multimedia, entertainment, public relations and branding firm. Under the terms of this six-month campaign, Hemp, Inc. will receive a full-page advertisement in each of Freedom Leaf magazine’s monthly print editions, as well as its related digital and social media platforms. Following the commencement of this agreement on September 1, 2015, the company’s advertisements will appear in tens of thousands of copies throughout 32 states.

“We expect this national campaign launch to bolster existing marketing efforts and maximize profits,” Bruce Perlowin, chief executive officer of Hemp, Inc., stated in a news release. “The upcoming advertisements across Freedom Leaf’s platforms are designed to be a ‘call-to-action’ to join the industrial hemp revolution and fight misleading propaganda and long-standing misinformation on the hemp plant.”

This campaign, which is a continuation of the company’s aggressive marketing strategy for its existing line, will highlight Hemp, Inc.’s popular selection of hemp-infused products – including shampoos, conditioners, moisturizers, lip balms, skin treatment oils and candles. Additionally, these advertising efforts coincide with the impending launch of the company’s 70,000 square-foot decortication plant. When operational, this plant is expected to be the largest natural fiber manufacturing and processing facility in North America.

“I believe Hemp, Inc. is a true pioneer in the industrial hemp industry and I have high hopes about the direction in which Hemp, Inc. is moving,” stated Clifford J. Perry, chief executive officer of Freedom Leaf. “Their decortication plant in Spring Hope, North Carolina, is going to change the way we do business and help transition from non-sustainable synthetic solutions to more hemp-based clean, green solutions.”

Although banned in the U.S. under the Marijuana Tax Act of 1937, industrial hemp has been making a comeback in recent years. In 2014, Congress passed the federal Farm Bill, which allowed some states to cultivate the plant for research purposes. In March, North Dakota Gov. Jack Dalrymple took it one step further by signing a bill into law that laid the groundwork for a commercial hemp industry in the state. For Hemp, Inc., this rising sentiment around the country could provide a platform for sustainable financial growth in the future.

To date, Hemp, Inc. has completed the first stage of four toward preparing its manufacturing facility for operation. While the company awaits the legalization of industrial hemp in North Carolina, it plans to use the facility to process kenaf, a commercial fiber crop related to cotton. For prospective shareholders, the popularity of Hemp, Inc.’s existing product lines, as well as the near limitless market potential presented by its decortication plant, makes the company an intriguing investment opportunity moving forward. Look for Hemp, Inc. to continue capitalizing on its position in one of the country’s most rapidly expanding markets while awaiting additional regulatory reform.

For more information, visit www.hempinc.com

International Stem Cell Corporation is a biotechnology company utilizing a proprietary new stem cell technology known as parthenogenesis to significantly advance the field of regenerative medicine. The company’s innovative technology uses unfertilized human eggs to create human pluripotent stem cells (hpSC) that can be immune-matched to millions of people around the globe. These stem cells are unique in that they provide the best characteristics of each of the remaining classes of cells without the need for the creation or destruction of a viable embryo.

The company’s business strategy features three unique channels for revenue generation within the biotechnology industry – including its core stem cell technology and related intellectual property, which encompasses 220 patents, applications and licenses associated with the development and manufacture of pluripotent cells, as well as its therapeutic research projects and promising development pipeline.

Lifeline Skin Care, the company’s wholly-owned subsidiary, is an industry leader in effective anti-aging stem cell skin care. Since being established in 2010, Lifeline has served as a growing source of vital financial support to fund ISCO’s ongoing medical research. In 2014, Lifeline accounted for more than $7 million in total revenue, which was primarily allocated to the advancement of the company’s promising development pipeline.

UniStemCell is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. This cell bank gives the company a nearly inexhaustible source of stem cells that can be used to generate revenue in the medium term. As the company’s hpSC lines gain additional validation, they are expected to provide the company with royalty from sales of each successful hpSC-derived cellular therapeutic in the future.

In addition to the sale of its stem cells, ISCO is making noteworthy progress toward the continued advancement of its development pipeline. The company is currently engaged in pre-clinical development addressing a host of unmet medical needs. Parkinson’s disease, which affects an estimated one million people in the United States, represents ISCO’s leading development indication, with phase I/II clinical trials expected to begin in the coming months. Following the completion of initial studies, the company will seek out a suitable partner to assist with late-stage clinical development.

With its groundbreaking stem cell technology, ISCO is developing a significant presence within the expansive field of regenerative medicine. By successfully mitigating many of the limiting factors commonly associated with stem cell research – including auto-immune rejection and ethical debate surrounding the use of embryonic cells – the company is leveraging the marketability of its technology as a catalyst for continued growth.

Research indicates that the global regenerative medicine market is expected to grow at a CAGR of 12.2 percent through 2017, climbing to an estimated $24.7 billion by the end of the period. ISCO will look to capitalize on this market performance under the guidance of an executive management team with decades of experience in a collection of related scientific sectors.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

On the Move Systems’ (OMVS) upcoming “Uber-for-Trucking” on-demand platform is expected to do well, especially since the nation’s trucking industry is currently in the midst of an impressive growth spurt. The company’s platform will offer freight haulers a cutting-edge technology based solution to encourage continued growth.

The American Trucking Associations (ATA) recently published its U.S. Freight Transportation Forecast, which boldly predicted the industry will enjoy a robust 29 percent increase in freight volumes by 2026. “The outlook for all modes of freight transportation remains bright,” said ATA Chief Economist Bob Costello. “Continued population growth, expansion of the energy sector and foreign trade will boost trucking, intermodal rail and pipeline shipments.”

While the industry outlook appears stunningly bright, there is one potential dark cloud on the horizon: a continuing driver shortage. Reports estimate trucking companies currently face a shortage of 35,000 drivers.

“These two news items definitely indicate a real opportunity for a technology solutions company like ours,” stated OMVS CEO Robert Wilson. “The predicted freight volume increase should drive demand for our shared economy platform, as firms will want to optimize these additional loads and routes. However, they’ll need drivers to haul these additional loads and our app can help there as well in connecting companies with local independent drivers wanting to contract with carriers. Our innovative platform looks like it will debut at a very opportune time.”

A recent industry outlook from Frost & Sullivan predicted trucking will soon see an Uber-style transformation, where shared economy platforms and apps, like the one now under development by OMVS, will play a major role in operations and revenue-generation.

For more information, visit www.onthemovesystems.com

Let us hear your thoughts: On the Move Systems Corp. Message Board

Today before the opening bell, the Aristocrat Group Corp. announced that its sponsored racecar will enter the Radical Cup Texas Round 4 race this weekend sitting in pole position. The RWB Vodka-branded car was declared the overall winner of the Radical Cup Round 3 event at NOLA Motorsports Park in New Orleans.

Select motorsports events have been key to ASCC’s marketing approach since RWB Vodka’s debut. RWB Vodka Racing’s SR3-RS car has taken a podium in every race entered and remains in the thick of the competition to become the season’s overall winner.

The RWB Vodka Racing team will compete against the field this weekend at MSR Houston in Angleton, Texas.

“At this point, the RWB Vodka car has won nearly as many trophies as the distilled spirit it represents,” said ASCC CEO Robert Federowicz. “We could not ask for a better brand ambassador in the world of motorsports.”

Having received 17 tasting awards over the past two years, RWB Ultra-Premium Handcrafted Vodka is among the most highly decorated American vodkas in the distilled spirits marketplace. It is the lynchpin of a growing portfolio of brands marketed and developed by the Aristocrat Group Corp. as the company works to capitalize on the rising commercial popularity of the domestic distilled spirits sector.

For more information on the Aristocrat Group Corp., visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

Latitude360 chairman, founder and CEO Brent Brown started developing the Latitude 360 concept in 2007, and over the last five years has amassed a strong staff of more than 500 employees and a growing foothold in the restaurant and entertainment industries. Widely recognized within Florida’s business world, Brown’s track record demonstrates his keen ability to transform a vision into a continuously growing, revenue-generating establishment.

Latitude 360 is an award-winning pioneer of a dining and entertainment venues that combine premier upscale casual dining with numerous state-of-the-art entertainment choices. The company develops, constructs and operates cutting-edge Latitude 360 venues ranging from 50,000-85,000 sq. ft., packed full of eating and entertainment options that appeal to a broad base of guests, private events and corporate clients.

The company’s three locations in Jacksonville, Florida, Pittsburgh, Pennsylvania, and Indianapolis, Indiana, encompass the Latitude brand of exceptional food and beverage combined with numerous entertainment options in an upscale venue. Key offerings at each 360 location include Las Vegas-style live performance showroom, a feature bar featuring the area’s top musicians and/or DJs, luxury bowling, dine-in movies, high-definition sports theatre, game arcade and luxury cigar lounge and many choices of private meeting space.

Seven years after Brown began laying the groundwork for Latitude 360, the company has established a first-of-its-kind, fee-based monthly club membership program through which guests have access to a cache of monthly entertainment assets at a value price as well as exclusive access to a 360 Club Concierge service. The program has quickly grown to more than 5,000 active monthly paying members.

In the first quarter of 2015, Latitude 360 reported gross sales of $6.4 million, up 19% compared to $5.4 million in the first quarter of 2014; net sales increased 4.45% compared to the prior-year quarter; and group sales increased 45% to $1.6 million compared to $1.1 million for the comparable quarter of 2014.

Brown’s growth strategies incorporate his more than 15 years of experience in various specialties, including management, leadership and start-up finance, project development, complex real estate development and acquisition, re-zoning, rental management and investment banking. Brown’s experience not only contributes to the success and growth of the Latitude 360 brand, it has also earned him some industry recognition.

Brown is a member of the YLC Advisory Committee for the Manhattan Institute, has served on the South East Vision Committee for the City of Jacksonville as well as sat on the board of trustees for the Jacksonville Chamber of Commerce, and has received a steady flow of awards:

• 2008 Jacksonville Business Journal ranked Brent in the Top 40 Businessman under 40
• 2012 The Ultimate CEO for Northeast Florida by the Jacksonville Business Journal
• 2013 Entrepreneur of the year by Entrepreneur Anchor Magazine
• 2014 Latitude 360 awarded the Florida Fast 100 Companies for the top 100 growth companies in Florida
• 2015 Top 10 Industry Ranking in The Jacksonville Business Journal’s 2015 Book of Lists
• He also is a Co-Founder of H.A.T.U.A. International

Latitude 360 recently expanded its entertainment offerings when it Partnered and pending acquisition of Major League Fantasy (MLF), a leader in the daily fantasy sports industry. By implementing “360 Fantasy Live” into is existing locations, Latitude 360 is making a strong entrance into a rapidly growing market expected to reach $6 billion-$10 billion by year-end 2016.

Many companies are taking advantage of growing demand for daily sports fantasy leagues, but while DraftTeamDaily Fantasy Sports Corp. (OTC:PMXRF), Buffalo Wild Wings (NASDAQ:BWLD) and even Yahoo!, Inc. (NASDAQ:YHOO) enjoy footing in the fantasy sports industry, the acquisition of MLF allows Latitude 360 to position itself as one of the first live, multimedia venues to offer in-house, high-stakes, competitive daily fantasy events.

Brown and his equally strong core management team have not only designed, developed, constructed and operate three Latitude 360 venues around the country, but also plan to open three new venues this year. With an established presence in current markets and three new locations on deck, Latitude 360’s management team has an eye not only on national expansion, but international expansion as well.

“It is our belief that the truest indication of our strength is indicated in our store level results. With three store locations opening in the very near future, we intend to continue to grow and expand, offering customers the best dining and entertainment experience available. Our strategy remains to continue to expand in the United States, expand internationally and increase sales at existing locations. We have made solid progress on these initiatives and look for these to continue into the remainder of 2015 and beyond,” Brown stated in an April news release.

For more information visit www.latitude360.com/corporate/investor-relations/

Let us hear your thoughts: Latitude 360, Inc. Message Board

While Tesla Motors, Inc. (TSLA) continues to make headlines with the rapid growth and development of its new battery grid business – with recent estimates forecasting $45 million in sales during the fourth quarter of this year – the resulting rise in demand for reliable battery systems is providing a platform for strong financial growth across the stored energy industry. Galenfeha, Inc. (OTC: GLFH), through the commercialization of its innovative lithium iron phosphate (LiFePO4) chemistry and patent-pending onboard battery management system, is capitalizing on this opportunity, expanding upon its current customer base through potentially lucrative distribution channels.

Last month, Galenfeha utilized this strategy to great success by partnering with ABB Group, a global leader in power and automation technologies. Through this agreement, the company expects to significantly expand its existing customer base while promoting improved financial returns in the months to come.

“It is a privilege to be represented in ABB’s product offerings,” Lucien Marioneaux, Jr., president and chief executive officer of Galenfeha, stated in a news release. “This affiliation will enable Galenfeha to significantly broaden its customer base locally, nationally, even internationally, and we couldn’t be more pleased with this development.”

Traditional lead-acid batteries have a collection of disadvantages that limit their effectiveness in most stored power applications – including inefficient charging and discharging, the production of gas byproducts during charging and heavy, bulky construction. Galenfeha’s proprietary LiFePO4 chemistry and onboard battery management system addresses each of these disadvantages, providing a light-weight, environmentally-friendly alternative with excellent thermal stability and an improved lifespan.

For solar power generation, these benefits can translate into significant cost savings for the company’s customers. In addition to eliminating the need for a solar regulator, Galenfeha’s battery management system increases charging efficiency, allowing for the use of smaller, more cost-effective solar panels.

In the first quarter of 2015, Galenfeha provided a preview of its tremendous market potential, recording a 173 percent quarter-over-quarter increase in total revenue on the way to a gross profit of approximately $122,000. For prospective shareholders, these results could foreshadow an opportunity for the company to promote sustainable returns moving forward. Look for Galenfeha to continue leaning on its groundbreaking product portfolio in order to build upon its recent progress toward expanding its customer base in the years to come.
Take a closer look at the company by visiting www.galenfeha.com.

Let us hear your thoughts: Galenfeha, Inc. Message Board

Earlier today, Arotech reported a $6.7 task order from the Space and Naval Warfare Center (SPAWAR) Atlantic. The contract came through its North American Power System Division, which includes UEC Electronics.

The contract awarded is for the manufacture and integration of 12 Communication Emitter Sensing and Attacking System (CESAS) II Platform Integration Kits (PIK). The CESAS is the Marine Corps’ only high-power, ground-mobile electronic attack (EA) asset. The CESAS provides Commanders with the capability to detect, deny, and disrupt the communications of their enemy.

“UEC Electronics has been supporting the SPAWAR Intelligence group for more than 10 years and is pleased with the most recent contract award,” said Mark Matthews, CEO of UEC Electronics. “The DoD is focused on cost savings. Our automated manufacturing processes, coupled with our history of quality products and on-time delivery, make us an ideal provider for this type of mission critical system.”

Arotech received this award following the successful completion of a prototype test of the CESAS II PIK, which performed exceptionally well during U.S. Government-led performance and environmental testing.

Arotech expects to complete this production contract in the next 12 months. The government has an option which, if exercised, will result in a second year of support for the program.

Steven Esses, President and CEO of Arotech, commented, “The award of this contract is a testament to our team and performance of our product. We are excited about the initial opportunity and are optimistic that this award could lead to the procurement of additional units in the future.”

For more information, visit www.arotech.com